Calumet Specialty Products Partners (CLMT) Misses Q4 EPS by 91c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/3/2026
- Nasdaq ends higher as AI heavyweights rebound ahead of midterm results
- Apple shares slip amid guidance for tightening margins, slowing services growth
- Rising shorts cool U.S. large-cap positioning, cutting liquidation risk: Citi
- Apple's 'unprecedented' memory warning adds fuel to wobbly Micron, SK hynix trade
- Palantir raises 2026 revenue outlook after quarterly revenue nearly doubles on AI
Tweet
Share
E-mailGet Alerts CLMT Hot Sheet
Price: $47.33 +1.28%
Revenue Growth %: +16.7%
Financial Fact:
Taxes other than income taxes: 4.8M
Today's EPS Names:
FUSE, INM, TRI, More
Revenue Growth %: +16.7%
Financial Fact:
Taxes other than income taxes: 4.8M
Today's EPS Names:
FUSE, INM, TRI, More
Join SI Premium – FREE
Calumet Specialty Products Partners (NASDAQ: CLMT) reported Q4 EPS of ($0.86), $0.91 worse than the analyst estimate of $0.05. Revenue for the quarter came in at $999.8 million versus the consensus estimate of $856.58 million.
For earnings history and earnings-related data on Calumet Specialty Products Partners (CLMT) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Ultragenyx Pharma (RARE) Misses Q3 EPS by 6c; Offers Guidance
- Tarsus Pharmaceuticals, Inc. (TARS) Misses Q3 EPS by 1293c
- Limbach Holdings (LMB) Tops Q3 EPS by 16c, Beats on Revenue; Offers FY26 Revenue Guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
